Weiner SM - Search Results

1

End-stage renal disease after treatment with 90Y-DOTATOC.

Cybulla M, Weiner SM, Otte A. Cybulla M, et al. Among authors: weiner sm. Eur J Nucl Med. 2001 Oct;28(10):1552-4. doi: 10.1007/s002590100599. Eur J Nucl Med. 2001. PMID: 11685499

2

Is (90)Y-DOTATOC treatment for neuroendocrine tumours safe?

Cybulla M, Weiner SM, Otte A. Cybulla M, et al. Among authors: weiner sm. Med Sci Monit. 2002 Apr;8(4):LE7. Med Sci Monit. 2002. PMID: 11951054 No abstract available.

3

90Y-DOTATOC and nephrotoxicity.

Otte A, Cybulla M, Weiner SM. Otte A, et al. Among authors: weiner sm. Eur J Nucl Med Mol Imaging. 2002 Nov;29(11):1543. doi: 10.1007/s00259-002-0935-x. Eur J Nucl Med Mol Imaging. 2002. PMID: 12537003 No abstract available.

4

Is radiation nephropathy caused by yttrium-90?

Otte A, Weiner SM, Cybulla M. Otte A, et al. Among authors: weiner sm. Lancet. 2002 Mar 16;359(9310):979; author reply 979. doi: 10.1016/S0140-6736(02)08002-9. Lancet. 2002. PMID: 11918946 No abstract available.

5

Renal toxicity after radionuclide therapy.

Lambert B, Cybulla M, Weiner SM, Van De Wiele C, Ham H, Dierckx RA, Otte A. Lambert B, et al. Among authors: weiner sm. Radiat Res. 2004 May;161(5):607-11. doi: 10.1667/rr3105. Radiat Res. 2004. PMID: 15161361 Review.

6

Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: a controlled positron emission tomography study.

Otte A, Weiner SM, Peter HH, Mueller-Brand J, Goetze M, Moser E, Gutfleisch J, Hoegerle S, Juengling FD, Nitzsche EU. Otte A, et al. Among authors: weiner sm. Eur J Nucl Med. 1997 Jul;24(7):787-91. doi: 10.1007/BF00879668. Eur J Nucl Med. 1997. PMID: 9211766

7

Neuro-Behçet's syndrome in a patient not fulfilling criteria for Behçet's disease: clinical features and value of brain imaging.

Weiner SM, Otte A, Schumacher M, Juengling FD, Brink I, Nitzsche EU, Peter HH, Kreisel W. Weiner SM, et al. Clin Rheumatol. 2000;19(3):231-4. doi: 10.1007/s100670050164. Clin Rheumatol. 2000. PMID: 10870662

8

Alterations of cerebral glucose metabolism indicate progress to severe morphological brain lesions in neuropsychiatric systemic lupus erythematosus.

Weiner SM, Otte A, Schumacher M, Brink I, Juengling FD, Sobanksi T, Nitzsche EU, Peter HH. Weiner SM, et al. Lupus. 2000;9(5):386-9. doi: 10.1191/096120300678828370. Lupus. 2000. PMID: 10878734

9

Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET.

Weiner SM, Otte A, Schumacher M, Klein R, Gutfleisch J, Brink I, Otto P, Nitzsche EU, Moser E, Peter HH. Weiner SM, et al. Ann Rheum Dis. 2000 May;59(5):377-85. doi: 10.1136/ard.59.5.377. Ann Rheum Dis. 2000. PMID: 10784521 Free PMC article.

10

Systemic lupus erythematosus.

Otte A, Weiner SM. Otte A, et al. Among authors: weiner sm. Lancet. 2001 Aug 18;358(9281):585-6. doi: 10.1016/S0140-6736(01)05728-2. Lancet. 2001. PMID: 11526928 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters